Danforth Advisors completed the acquisition of PharmaDirections.

Danforth Advisors, a life science industry’s trusted partner for strategic and operational support across business, clinical, and commercial functions, completed the acquisition of PharmaDirections, a full-spectrum development partner to life science companies. Financial terms were not disclosed. “PharmaDirections and Danforth share more than capabilities – we share a philosophy of partnership and problem-solving for life science companies. By bringing our teams together, we’re creating a unified resource that helps innovators overcome the most complex challenges in drug development while keeping the mission – getting new therapies to patients – at the heart of everything we do," Chris Connors, Danforth Advisors CEO.